Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AXSMAxsome Therapeutics, Inc.

Nasdaq · CIK 0001579428
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts304

Identity from submissions API

NameAxsome Therapeutics, Inc.
CIK0001579428
TickersAXSM
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN454241907
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(212) 332-3241
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
ONE WORLD TRADE CENTER, 29TH FLOOR
NEW YORK
NY
10007
NY
Mailing address
ONE WORLD TRADE CENTER, 29TH FLOOR
NEW YORK
NY
10007
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

672 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-02 10-Q 10-Q 0001193125-26-443752 001-37635 261512855 34 13796468 1 1
2026-11-02 8-K 8-K 2.02,8.01,9.01 0001193125-26-442628 001-37635 261509870 34 21702003 1 1
2026-09-03 4 4 0001193125-26-382277 8820
2026-09-03 144 xsl144X01/primary_doc.xml 0001958244-26-000571 001-37635 261359466 33 5338
2026-08-10 10-Q 10-Q 0001193125-26-342360 001-37635 261258418 34 13423852 1 1
2026-08-10 8-K 8-K 2.02,8.01,9.01 0001193125-26-341206 001-37635 261256167 34 18565683 1 1
2026-08-07 4 4 0001193125-26-340688 15046
2026-08-06 144 xsl144X01/primary_doc.xml 0001958244-26-000491 001-37635 261250337 33 10348
2026-08-05 144 xsl144X01/primary_doc.xml 0001958244-26-000488 001-37635 261245181 33 8697
2026-07-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002197 005-89198 261206046 34 11157
2026-07-15 8-K 8-K 8.01,9.01 0001193125-26-304039 001-37635 261175854 34 196093 1 1
2026-07-01 4 4 0001193125-26-292985 9825
2026-07-01 144 xsl144X01/primary_doc.xml 0001958244-26-000417 001-37635 261146727 33 7045
2026-06-11 4 4 0001193125-26-268202 6195
2026-06-11 144 xsl144X01/primary_doc.xml 0001921094-26-000636 001-37635 261084059 33 4772
2026-06-10 4 4 0001193125-26-266437 6749
2026-06-10 4 4 0001193125-26-266436 7929
2026-06-10 4 4 0001193125-26-266435 10108
2026-06-10 4 4 0001193125-26-266433 9800
2026-06-10 144 xsl144X01/primary_doc.xml 0001921094-26-000633 001-37635 261079886 33 4936
2026-06-10 144 xsl144X01/primary_doc.xml 0001921094-26-000632 001-37635 261079874 33 4159
2026-06-10 144 xsl144X01/primary_doc.xml 0001921094-26-000631 001-37635 261079860 33 6127
2026-06-09 144 xsl144X01/primary_doc.xml 0001958244-26-000358 001-37635 261077358 33 5391
2026-06-09 8-K 8-K 5.02,9.01 0001193125-26-264047 001-37635 261077178 34 488556 1 1
2026-06-09 8-K 8-K 5.07,9.01 0001193125-26-264043 001-37635 261077173 34 189613 1 1
2026-06-09 4 4 0001193125-26-264041 5374
2026-06-09 4 4 0001193125-26-264040 5421
2026-06-09 4 4 0001193125-26-264038 9825
2026-06-09 4 4 0001193125-26-264035 9928
2026-06-09 4 4 0001193125-26-264034 5468
2026-06-09 4 4 0001193125-26-264030 5259
2026-06-09 144 xsl144X01/primary_doc.xml 0001921094-26-000619 001-37635 261076151 33 4290
2026-06-09 144 xsl144X01/primary_doc.xml 0001921094-26-000618 001-37635 261076114 33 4322
2026-06-03 8-K 8-K 8.01,9.01 0001193125-26-254708 001-37635 261059146 34 185278 1 1
2026-06-02 4 4 0001193125-26-254038 9266
2026-06-02 144 xsl144X01/primary_doc.xml 0001921094-26-000584 001-37635 261056048 33 5493
2026-06-01 144 xsl144X01/primary_doc.xml 0001921094-26-000574 001-37635 261050666 33 4876
2026-05-29 144 xsl144X01/primary_doc.xml 0001921094-26-000571 001-37635 261044420 33 4259
2026-05-05 4 4 0001193125-26-207148 14032
2026-05-05 144 xsl144X01/primary_doc.xml 0001958244-26-000257 001-37635 26944985 33 7811
2026-05-05 144/A xsl144X01/primary_doc.xml 0001958244-26-000256 001-37635 26944982 33 7044
2026-05-04 144 xsl144X01/primary_doc.xml 0001958244-26-000251 001-37635 26939381 33 6881
2026-05-04 10-Q 10-Q 0001193125-26-204274 001-37635 26938890 34 11686565 1 1
2026-05-04 8-K 8-K 2.02,8.01,9.01 0001193125-26-202506 001-37635 26934592 34 19266375 1 1
2026-04-30 8-K 8-K 8.01,9.01 0001193125-26-197857 001-37635 26927272 34 288697 1 1
2026-04-24 ARS ARS 0001193125-26-177614 001-37635 26895560 34 1357938
2026-04-24 DEFA14A DEFA14A 0001193125-26-177613 001-37635 26895535 34 7765716
2026-04-24 DEF 14A DEF 14A 0001193125-26-177610 001-37635 26895511 34 19850900 1 1
2026-04-23 4 4 0001193125-26-174419 5525
2026-04-23 4 4 0001193125-26-174417 5577
2026-04-23 4 4 0001193125-26-174415 8560
2026-04-23 4 4 0001193125-26-174413 5521
2026-04-23 4 4 0001193125-26-174412 5500
2026-04-23 4 4 0001193125-26-174411 5515
2026-04-22 144 xsl144X01/primary_doc.xml 0001921094-26-000410 001-37635 26883678 33 4307
2026-04-01 8-K 8-K 8.01,9.01 0001193125-26-135669 001-37635 26824659 34 201975 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000783 005-89198 26798344 34 7142
2026-02-27 4 4 0001193125-26-083609 5983
2026-02-27 4 4 0001193125-26-083608 5909
2026-02-27 4 4 0001193125-26-083607 5924
2026-02-27 4 4 0001193125-26-083606 5930
2026-02-27 4 4 0001193125-26-083605 5934
2026-02-27 4 4 0001193125-26-083587 5839
2026-02-27 4 4 0001193125-26-083586 8655
2026-02-26 144 xsl144X01/primary_doc.xml 0001958244-26-000103 001-37635 26690131 33 5343
2026-02-26 144 xsl144X01/primary_doc.xml 0001921094-26-000210 001-37635 26688550 33 5344
2026-02-25 4 4 0001193125-26-072481 7592
2026-02-23 4 4 0001193125-26-064681 7596
2026-02-23 10-K 10-K 0001193125-26-064267 001-37635 26666227 34 19600621 1 1
2026-02-23 8-K 8-K 2.02,9.01 0001193125-26-062421 001-37635 26662066 34 480624 1 1
2026-02-17 8-K 8-K 8.01,9.01 0001193125-26-053009 001-37635 26636333 34 187365 1 1
2026-02-10 4 4 0001193125-26-045110 7589
2026-02-02 4 4 0001193125-26-033973 9713
2026-02-02 144 xsl144X01/primary_doc.xml 0001958244-26-000063 001-37635 26589104 33 16137
2026-01-23 4 4 0001193125-26-021378 9756
2026-01-23 4 4 0001193125-26-021377 8423
2026-01-22 144 xsl144X01/primary_doc.xml 0001921094-26-000055 001-37635 26551560 33 4289
2026-01-21 144 xsl144X01/primary_doc.xml 0001921094-26-000051 001-37635 26547888 33 4307
2026-01-12 8-K 8-K 2.02,8.01,9.01 0001193125-26-009744 001-37635 26524643 34 269659 1 1
2026-01-07 4 4 0001193125-26-006695 20087
2026-01-07 144 xsl144X01/primary_doc.xml 0001958244-26-000028 001-37635 26516253 33 16966
2026-01-06 144 xsl144X01/primary_doc.xml 0001958244-26-000021 001-37635 26512540 33 16962
2026-01-05 144 xsl144X01/primary_doc.xml 0001958244-26-000014 001-37635 26507809 33 15204
2026-01-02 4 4 0001193125-26-001181 14675
2025-12-31 144 xsl144X01/primary_doc.xml 0001921094-25-001592 001-37635 251617423 33 4399
2025-12-31 8-K 8-K 8.01,9.01 0001193125-25-337644 001-37635 251615726 34 400991 1 1
2025-12-04 4 4 0001193125-25-308354 20091
2025-12-04 144 xsl144X01/primary_doc.xml 0001958244-25-004519 001-37635 251550558 33 16966
2025-12-03 144 xsl144X01/primary_doc.xml 0001958244-25-004511 001-37635 251547586 33 16140
2025-12-02 144 xsl144X01/primary_doc.xml 0001958244-25-004504 001-37635 251544067 33 14487
2025-11-05 144 xsl144X01/primary_doc.xml 0001958244-25-004438 001-37635 251455564 33 13660
2025-11-05 4 4 0001193125-25-267467 20091
2025-11-04 144 xsl144X01/primary_doc.xml 0001958244-25-004433 001-37635 251450954 33 12007
2025-11-03 144 xsl144X01/primary_doc.xml 0001958244-25-004427 001-37635 251445521 33 10354
2025-11-03 S-3ASR S-3ASR 0001193125-25-262696 333-291228 251444836 33 1867153 1 1
2025-11-03 10-Q 10-Q 0001193125-25-262664 001-37635 251444713 34 12819015 1 1
2025-11-03 8-K 8-K 2.02,8.01,9.01 0001193125-25-261651 001-37635 251442085 34 20004966 1 1
2025-10-08 4 4 0001193125-25-234881 20091
2025-10-08 144 xsl144X01/primary_doc.xml 0001958244-25-004387 001-37635 251382972 33 9527
2025-10-07 144 xsl144X01/primary_doc.xml 0001958244-25-004383 001-37635 251380352 33 8698
2025-10-06 144 xsl144X01/primary_doc.xml 0001958244-25-004372 001-37635 251377328 33 7871
2025-09-22 4 4 0001193125-25-211788 8689
2025-09-22 144 xsl144X01/primary_doc.xml 0001921094-25-001190 001-37635 251330170 33 4938
2025-09-17 4 4 0001193125-25-206494 13897
2025-09-16 4 4 0001193125-25-205260 20112
2025-09-16 144 xsl144X01/primary_doc.xml 0001921094-25-001167 001-37635 251318240 33 4859
2025-09-16 144 xsl144X01/primary_doc.xml 0001958244-25-004338 001-37635 251317889 33 7044
2025-09-15 144 xsl144X01/primary_doc.xml 0001958244-25-004332 001-37635 251315347 33 6218
2025-09-12 144 xsl144X01/primary_doc.xml 0001958244-25-004329 001-37635 251312803 33 5235
2025-09-09 4 4 0000950170-25-113874 8263
2025-09-05 4 4 0000950170-25-113311 9713
2025-09-05 144 xsl144X01/primary_doc.xml 0001921094-25-001106 001-37635 251297436 33 4380
2025-09-02 4 4 0001231615-25-000008 4758
2025-09-02 144 xsl144X01/primary_doc.xml 0001921094-25-001057 001-37635 251285138 33 7771
2025-08-29 4 4 0001231615-25-000006 8052
2025-08-29 144 xsl144X01/primary_doc.xml 0001921094-25-001050 001-37635 251280730 33 6613
2025-08-28 144 xsl144X01/primary_doc.xml 0001921094-25-001043 001-37635 251273325 33 6538
2025-08-27 144 xsl144X01/primary_doc.xml 0001921094-25-001039 001-37635 251265350 33 5921
2025-08-26 4 4 0001231615-25-000004 6392
2025-08-26 144 xsl144X01/primary_doc.xml 0001921094-25-001033 001-37635 251257666 33 5304
2025-08-22 144 xsl144X01/primary_doc.xml 0001921094-25-001014 001-37635 251246641 33 5228
2025-08-20 8-K 8-K 8.01,9.01 0001579428-25-000007 001-37635 251237571 34 146981 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-021702 005-89198 251214461 34 10163
2025-08-07 S-8 S-8 0000950170-25-105192 333-289385 251195022 33 342477 1 1
2025-08-04 10-Q 10-Q 0000950170-25-102148 001-37635 251181615 34 16342831 1 1
2025-08-04 8-K 8-K 2.02,8.01,9.01 0000950170-25-101624 001-37635 251178035 34 20316320 1 1
2025-06-23 4 4 0000950170-25-089158 13562
2025-06-23 144 xsl144X01/primary_doc.xml 0001921094-25-000710 001-37635 251064921 33 6797
2025-06-20 144 xsl144X01/primary_doc.xml 0001921094-25-000702 001-37635 251061397 33 6176
2025-06-18 4 4 0000950170-25-088105 18649
2025-06-18 144 xsl144X01/primary_doc.xml 0001921094-25-000693 001-37635 251057494 33 5555
2025-06-17 144 xsl144X01/primary_doc.xml 0001921094-25-000689 001-37635 251053229 33 4934
2025-06-16 144 xsl144X01/primary_doc.xml 0001921094-25-000670 001-37635 251050307 33 4313
2025-06-10 4 4 0000950170-25-084560 7391
2025-06-10 4 4 0000950170-25-084559 7276
2025-06-10 4 4 0000950170-25-084555 7468
2025-06-10 4 4 0000950170-25-084556 8673
2025-06-10 4 4 0000950170-25-084554 7383
2025-06-10 8-K 8-K 8.01,9.01 0000950170-25-084098 001-37635 251035935 34 363218 1 1
2025-06-09 8-K 8-K 5.07,9.01 0000950170-25-083793 001-37635 251034540 34 199430 1 1
2025-06-09 144 xsl144X01/primary_doc.xml 0001921094-25-000627 001-37635 251034106 33 5559
2025-06-09 8-K 8-K 8.01,9.01 0000950170-25-083441 001-37635 251032811 34 270377 1 1
2025-05-29 4 4 0000950170-25-079229 7480
2025-05-28 4 4 0000950170-25-078552 13866
2025-05-28 144 xsl144X01/primary_doc.xml 0001921094-25-000564 001-37635 25996281 33 5489
2025-05-28 144 xsl144X01/primary_doc.xml 0001921094-25-000563 001-37635 25996268 33 4937
2025-05-27 144 xsl144X01/primary_doc.xml 0001921094-25-000562 001-37635 25989418 33 4310
2025-05-27 144 xsl144X01/primary_doc.xml 0001921094-25-000561 001-37635 25989400 33 4873
2025-05-27 8-K 8-K 8.01,9.01 0000950170-25-077374 001-37635 25984172 34 262530 1 1
2025-05-20 4 4 0000950170-25-075539 5685
2025-05-20 144 xsl144X01/primary_doc.xml 0001921094-25-000534 001-37635 25970308 33 4148
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-072022 005-89198 25948838 34 10192
2025-05-13 8-K 8-K 1.01,1.02,2.03,3.02,8.01,9.01 0000950170-25-069785 001-37635 25937098 34 294216 1 1
2025-05-05 10-Q 10-Q 0000950170-25-063634 001-37635 25913707 34 11917493 1 1
2025-05-05 8-K 8-K 2.02,8.01,9.01 0000950170-25-063158 001-37635 25910929 34 20537710 1 1
2025-04-25 ARS ARS 0000950170-25-058788 001-37635 25874682 34 6105235
2025-04-25 DEFA14A DEFA14A 0000950170-25-058785 001-37635 25874649 34 3659328
2025-04-25 DEF 14A DEF 14A 0000950170-25-058781 001-37635 25874627 34 12680521 1 1
2025-04-01 8-K 8-K 8.01,9.01 0000950170-25-048036 001-37635 25796551 34 279689 1 1
2025-03-25 8-K 8-K 8.01,9.01 0000950170-25-044096 001-37635 25765827 34 285293 1 1
2025-03-05 8-K 8-K 8.01,9.01 0000950170-25-033064 001-37635 25708797 34 266162 1 1
2025-03-03 8-K 8-K 8.01,9.01 0000950170-25-030395 001-37635 25693739 34 276983 1 1
2025-02-25 4 4 0000950170-25-027090 5200
2025-02-25 4 4 0000950170-25-027086 5093
2025-02-25 4 4 0000950170-25-027076 5285
2025-02-25 4 4 0000950170-25-027074 10504
2025-02-25 4 4 0000950170-25-027072 10498
2025-02-25 4 4 0000950170-25-027070 10483
2025-02-25 4 4 0000950170-25-027065 10517
2025-02-25 4 4 0000950170-25-027063 10410
2025-02-18 10-K 10-K 0000950170-25-022457 001-37635 25636079 34 21729974 1 1
2025-02-18 8-K 8-K 2.02,8.01,9.01 0000950170-25-021801 001-37635 25632716 34 21122753 1 1
2025-02-14 4 4 0000950170-25-021716 14782
2025-02-14 144 xsl144X01/primary_doc.xml 0001921094-25-000134 001-37635 25628601 33 4910
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-020479 005-89198 25623662 34 10217
2025-02-13 144 xsl144X01/primary_doc.xml 0001921094-25-000118 001-37635 25620040 33 4296
2025-02-10 8-K 8-K 8.01,9.01 0000950170-25-016678 001-37635 25603628 34 272095 1 1
2025-01-31 8-K 8-K 8.01,9.01 0000950170-25-011220 001-37635 25575124 34 333125 1 1
2025-01-13 8-K 8-K 2.02,8.01,9.01 0000950170-25-004559 001-37635 25524767 34 210095 1 1
2025-01-06 4 4 0000950170-25-002052 7582
2024-12-30 8-K 8-K 8.01,9.01 0000950170-24-140949 001-37635 241586965 34 13776098 1 1
2024-11-26 8-K 8-K 8.01,9.01 0000950170-24-130755 001-37635 241498142 34 256530 1 1
2024-11-20 4 4 0000950170-24-129330 7592
2024-11-12 10-Q 10-Q 0000950170-24-124758 001-37635 241444347 34 10815800 1 1
2024-11-12 8-K 8-K 2.02,8.01,9.01 0000950170-24-124546 001-37635 241443225 34 21956217 1 1
2024-10-24 3 3 0000950170-24-117142 20576
2024-10-01 8-K 8-K 1.01,9.01 0000950170-24-110957 001-37635 241344471 34 152514 1 1
2024-09-11 4 4 0000950170-24-105616 9695
2024-09-11 144 xsl144X01/primary_doc.xml 0001921094-24-001184 001-37635 241293000 33 4389
2024-09-04 8-K 8-K 8.01,9.01 0000950170-24-103098 001-37635 241275845 34 206531 1 1
2024-08-21 8-K 8-K 8.01,9.01 0000950170-24-099389 001-37635 241227194 34 200519 1 1
2024-08-09 4 4 0000950170-24-094967 8678
2024-08-09 144 xsl144X01/primary_doc.xml 0001921094-24-001015 001-37635 241193905 33 4943
2024-08-05 S-8 S-8 0000950170-24-090848 333-281249 241175358 33 284043 1 1
2024-08-05 10-Q 10-Q 0000950170-24-090828 001-37635 241175263 34 10236948 1 1
2024-08-05 8-K 8-K 2.02,9.01 0000950170-24-090311 001-37635 241173078 34 463941 1 1
2024-06-11 4 4 0000950170-24-071965 5154
2024-06-11 4 4 0000950170-24-071964 5162
2024-06-11 4 4 0000950170-24-071962 5047
2024-06-11 4 4 0000950170-24-071961 5239
2024-06-11 8-K 8-K 5.07,9.01 0000950170-24-071960 001-37635 241036225 34 187506 1 1
2024-06-05 8-K 8-K 8.01,9.01 0000950170-24-069077 001-37635 241020739 34 202716 1 1
2024-05-29 4 4 0000950170-24-066177 8627
2024-05-29 4 4 0000950170-24-066175 6519
2024-05-29 144 xsl144X01/primary_doc.xml 0001921094-24-000699 001-37635 24998797 33 4832
2024-05-29 144 xsl144X01/primary_doc.xml 0001921094-24-000698 001-37635 24998758 33 4880
2024-05-28 144 xsl144X01/primary_doc.xml 0001921094-24-000685 001-37635 24992308 33 4806
2024-05-06 10-Q 10-Q 0000950170-24-053697 001-37635 24918672 34 9460247 1 1
2024-05-06 8-K 8-K 2.02,9.01 0000950170-24-053197 001-37635 24915521 34 397942 1 1
2024-04-26 ARS ARS 0000950170-24-049222 001-37635 24884451 34 4696129
2024-04-26 DEF 14A DEF 14A 0000950170-24-049221 001-37635 24884432 34 32968684 1 1
2024-04-01 4 4 0000950170-24-039617 8435
2024-04-01 144 xsl144X01/primary_doc.xml 0001921094-24-000504 001-37635 24811485 33 4324
2024-04-01 8-K 8-K 8.01,9.01 0000950170-24-038894 001-37635 24805704 34 207300 1 1
2024-03-25 8-K 8-K 8.01,9.01 0000950170-24-035656 001-37635 24777057 34 224960 1 1
2024-03-25 8-K 8-K 8.01,9.01 0000950170-24-035655 001-37635 24777040 34 11352259 1 1
2024-03-19 8-K 8-K 8.01,9.01 0000950170-24-033148 001-37635 24761068 34 207988 1 1
2024-03-15 4 4 0000950170-24-032432 19034
2024-03-15 144 xsl144X01/primary_doc.xml 0001921094-24-000410 001-37635 24756470 33 4810
2024-03-14 144 xsl144X01/primary_doc.xml 0001921094-24-000384 001-37635 24750446 33 4196
2024-02-29 4 4 0000950170-24-023375 5103
2024-02-29 4 4 0000950170-24-023374 5295
2024-02-29 4 4 0000950170-24-023373 8127
2024-02-29 4 4 0000950170-24-023364 8103
2024-02-29 4 4 0000950170-24-023354 8021
2024-02-29 4 4 0000950170-24-023351 5190
2024-02-29 4 4 0000950170-24-023302 8117
2024-02-23 10-K 10-K 0000950170-24-019118 001-37635 24667298 34 13264387 1 1
2024-02-20 8-K 8-K 8.01,9.01 0000950170-24-017174 001-37635 24653960 34 18649928 1 1
2024-02-20 8-K 8-K 2.02,9.01 0000950170-24-016797 001-37635 24650677 34 433212 1 1
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023534 005-89198 24637100 34 121171
2024-02-14 SC 13G/A AXSOME THERAPEUTICS, INC. 0000902664-24-001555 005-89198 24632283 34 63329
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020385 005-89198 24627457 34 13053
2024-01-26 SC 13G/A us05464t1043_012624.txt 0001086364-24-004823 005-89198 24569156 34 13700
2024-01-08 8-K 8-K 8.01,9.01 0000950170-24-002685 001-37635 24518310 34 18366285 1 1
2024-01-04 8-K 8-K 2.02,8.01,9.01 0000950170-24-001488 001-37635 24509749 34 306642 1 1
2023-12-07 8-K 8-K 8.01,9.01 0000950170-23-068798 001-37635 231472397 34 46147516 1 1
2023-11-06 10-Q 10-Q 0000950170-23-059470 001-37635 231380473 34 11841306 1 1
2023-11-06 8-K 8-K 2.02,9.01 0000950170-23-059008 001-37635 231378084 34 540451 1 1
2023-10-12 4 FORM 4 SUBMISSION 0001209191-23-052736 7630
2023-10-12 3 FORM 3 SUBMISSION 0001209191-23-052734 6467
2023-10-11 8-K 8-K 5.02,7.01,9.01 0000950170-23-052940 001-37635 231321261 34 222767 1 1
2023-09-15 144 xsl144X01/primary_doc.xml 0001921094-23-000676 001-37635 231259779 33 4952
2023-09-15 4 FORM 4 SUBMISSION 0001209191-23-049648 10754
2023-08-15 8-K 8-K 8.01,9.01 0000950170-23-042629 001-37635 231173224 34 15740076 1 1
2023-08-07 10-Q 10-Q 0000950170-23-039178 001-37635 231148569 34 11684982 1 1
2023-08-07 8-K 8-K 2.02,9.01 0000950170-23-039035 001-37635 231147497 34 600483 1 1
2023-08-04 8-K 8-K 8.01,9.01 0000950170-23-038616 001-37635 231144655 34 170020 1 1
2023-07-07 SC 13G SC 13G 0001104659-23-079094 005-89198 231076726 34 131698
2023-07-07 8-K 8-K 8.01,9.01 0000950170-23-032152 001-37635 231075246 34 237668 1 1
2023-06-30 8-K 8-K 8.01,9.01 0000950170-23-031096 001-37635 231061706 34 204021 1 1
2023-06-29 424B5 424B5 0000950170-23-030499 333-268664 231053927 33 1010171
2023-06-29 8-K 8-K 8.01,9.01 0000950170-23-030493 001-37635 231053898 34 788695 1 1
2023-06-28 424B5 424B5 0000950170-23-030261 333-268664 231048974 33 856600
2023-06-26 8-K 8-K 4.01,9.01 0000950170-23-029901 001-37635 231043044 34 182054 1 1
2023-06-23 S-8 S-8 0000950170-23-029660 333-272891 231038245 33 239505
2023-06-13 8-K 8-K 9.01 0000950170-23-027770 001-37635 231012217 34 15131885 1 1
2023-06-08 8-K 8-K 5.02,5.07,9.01 0000950170-23-027059 001-37635 231002765 34 365087 1 1
2023-06-06 4 FORM 4 SUBMISSION 0001209191-23-034850 5384
2023-06-06 4 FORM 4 SUBMISSION 0001209191-23-034849 5192
2023-06-06 4 FORM 4 SUBMISSION 0001209191-23-034847 5307
2023-05-09 S-8 S-8 0000950170-23-018997 333-271741 23899422 33 197017
2023-05-09 10-Q 10-Q 0000950170-23-018976 001-37635 23899374 34 12475971 1 1
2023-05-08 8-K 8-K 2.02,9.01 0000950170-23-018467 001-37635 23895821 34 537086 1 1
2023-04-21 ARS ARS 0000950170-23-013884 001-37635 23837371 34 12213674
2023-04-21 DEF 14A DEF 14A 0000950170-23-013882 001-37635 23837362 34 12521488 1 1
2023-03-13 8-K 8-K 7.01,9.01 0000950170-23-007401 001-37635 23725539 34 178252 1 1
2023-03-10 8-K 8-K 7.01,9.01 0000950170-23-007250 001-37635 23723422 34 172642 1 1
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016459 8279
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016458 8381
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016457 8356
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016456 8367
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016455 5323
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016454 5208
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016453 5400
2023-02-28 10-K 10-K 0000950170-23-004728 001-37635 23676890 34 16007029 1 1
2023-02-27 8-K 8-K 2.02,9.01 0000950170-23-004474 001-37635 23670020 34 555981 1 1
2023-02-22 8-K 8-K 1.01,8.01,9.01 0000950170-23-003568 001-37635 23650520 34 289228 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021952 005-89198 23631474 34 195979
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021579 005-89198 23628965 34 98865
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021435 005-89198 23628177 34 111545
2023-02-14 SC 13G AXSOME THERAPEUTICS, INC. 0000902664-23-001720 005-89198 23623849 34 66763
2023-02-13 8-K 8-K 8.01 0000950170-23-002531 001-37635 23614627 34 172053 1 1
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015409 005-89198 23602522 34 12962
2023-02-01 SC 13G/A us05464t1043_020123.txt 0001306550-23-006465 005-89198 23577559 34 13398
2023-01-09 8-K 8-K 1.01,8.01,9.01 0000950170-23-000427 001-37635 23516523 34 176070 1 1
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-000870 7798
2022-12-02 S-3ASR S-3ASR 2022 0001564590-22-038976 333-268664 221443109 33 1672727
2022-11-28 8-K 8-K 8.01,9.01 0000950170-22-025706 001-37635 221421096 34 294358 1 1
2022-11-14 8-K 8-K 2.01,9.01 0000950170-22-025086 001-37635 221387919 34 176195 1 1
2022-11-07 10-Q 10-Q 0000950170-22-022710 001-37635 221366389 34 10766135 1 1
2022-11-07 8-K 8-K 2.02,9.01 0000950170-22-022315 001-37635 221363689 34 506034 1 1
2022-10-26 SC 13G SC 13G 0001104659-22-111285 005-89198 221330896 34 115473
2022-10-24 SC 13G SC 13G 0001104659-22-110914 005-89198 221326103 34 104334
2022-10-20 8-K 8-K 8.01,9.01 0000950170-22-019762 001-37635 221319747 34 394196 1 1
2022-10-03 8-K 8-K 8.01,9.01 0000950170-22-019151 001-37635 221285922 34 330687 1 1
2022-09-29 8-K 8-K 8.01,9.01 0000950170-22-018989 001-37635 221277686 34 285549 1 1
2022-09-08 8-K 8-K 8.01,9.01 0000950170-22-018238 001-37635 221233894 34 285685 1 1
2022-09-01 8-K 8-K 8.01,9.01 0000950170-22-018036 001-37635 221221032 34 283927 1 1
2022-08-23 8-K 8-K 2.02,8.01 0000950170-22-017665 001-37635 221185062 34 176891 1 1
2022-08-22 8-K 8-K 8.01,9.01 0001193125-22-225573 001-37635 221182026 34 159188 1 1
2022-08-22 424B5 424B5 0001193125-22-225572 333-235372 221182024 33 1003123
2022-08-19 8-K 8-K 8.01,9.01 0001193125-22-224610 001-37635 221178926 34 243625 1 1
2022-08-09 10-Q 10-Q 0000950170-22-016143 001-37635 221149175 34 10666710 1 1
2022-08-09 8-K 8-K 8.01,9.01 0000950170-22-015740 001-37635 221146347 34 480596 1 1
2022-07-21 8-K/A 8-K/A 9.01 0000950170-22-012884 001-37635 221097553 34 1637322 1 1
2022-06-28 8-K 8-K 8.01,9.01 0000950170-22-012281 001-37635 221051051 34 6712569 1 1
2022-06-27 8-K 8-K 8.01 0000950170-22-012137 001-37635 221041572 34 159678 1 1
2022-06-15 3 FORM 3 SUBMISSION 0001209191-22-036955 8987
2022-06-07 4 FORM 4 SUBMISSION 0001209191-22-034826 5347
2022-06-07 4 FORM 4 SUBMISSION 0001209191-22-034823 5155
2022-06-07 4 FORM 4 SUBMISSION 0001209191-22-034820 5270
2022-06-07 8-K 8-K 5.07,9.01 0000950170-22-011269 001-37635 221001278 34 214273 1 1
2022-06-02 8-K 8-K 8.01,9.01 0000950170-22-011048 001-37635 22989250 34 280052 1 1
2022-06-01 8-K 8-K 8.01 0000950170-22-010980 001-37635 22985944 34 279307 1 1
2022-05-31 8-K 8-K 8.01 0000950170-22-010892 001-37635 22980418 34 274351 1 1
2022-05-18 8-K 8-K 8.01 0000950170-22-010230 001-37635 22937021 34 277419 1 1
2022-05-09 8-K 8-K 2.01,2.03,3.02,8.01,9.01 0001193125-22-144265 001-37635 22903212 34 213807 1 1
2022-05-02 S-8 S-8 0001564590-22-017105 333-264621 22883189 33 128263
2022-05-02 10-Q 10-Q 0000950170-22-006901 001-37635 22883102 34 10768620 1 1
2022-05-02 8-K 8-K 2.02,8.01,9.01 0000950170-22-006770 001-37635 22879357 34 498128 1 1
2022-04-25 8-K 8-K 8.01 0000950170-22-006038 001-37635 22847301 34 159274 1 1
2022-04-22 DEF 14A DEF 14A 0000950170-22-006020 001-37635 22846360 34 7036447
2022-04-19 8-K 8-K 8.01 0000950170-22-005776 001-37635 22833446 34 157119 1 1
2022-03-31 8-K/A 8-K/A 1.01,9.01 0000950170-22-005231 001-37635 22793487 34 1186628 1 1
2022-03-28 8-K 8-K 1.01,8.01,9.01 0000950170-22-004722 001-37635 22773222 34 1362274 1 1
2022-03-17 4 FORM 4 SUBMISSION 0001209191-22-019403 7798
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017162 8282
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017159 8381
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017158 8356
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017156 5323
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017155 5208
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017153 5400
2022-03-01 424B5 424B5 0000950170-22-002581 333-235372 22699811 33 1475474
2022-03-01 8-K 8-K 1.01,9.01 0000950170-22-002576 001-37635 22699556 34 761196 1 1
2022-03-01 10-K 10-K 0000950170-22-002568 001-37635 22699244 34 11538834 1 1
2022-03-01 8-K 8-K 2.02,9.01 0000950170-22-002410 001-37635 22693908 34 420113 1 1
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-016587 005-89198 22606503 34 12957
2022-02-07 8-K 8-K 8.01 0000950170-22-000827 001-37635 22597341 34 161992 1 1
2022-02-03 SC 13G/A us05464t1043_020322.txt 0000834237-22-006427 005-89198 22589200 34 13371
2022-01-18 SC 13G/A axsome13ga112312021.htm 0001033427-22-000003 005-89198 22535103 34 48855
2022-01-18 8-K 8-K 8.01 0000950170-22-000347 001-37635 22533614 34 158671 1 1
2021-11-23 4 FORM 4 SUBMISSION 0001209191-21-066287 5175
2021-11-22 4 FORM 4 SUBMISSION 0001209191-21-066005 12022
2021-11-22 4 FORM 4 SUBMISSION 0001209191-21-066004 7263
2021-11-19 4 FORM 4 SUBMISSION 0001209191-21-065696 9816
2021-11-15 4 FORM 4 SUBMISSION 0001209191-21-064589 5378
2021-11-15 4 FORM 4 SUBMISSION 0001209191-21-064588 5403
2021-11-10 8-K 8-K 7.01 0000950170-21-004167 001-37635 211397896 34 167995 1 1
2021-11-08 10-Q 10-Q 0000950170-21-003466 001-37635 211388075 34 8303053 1 1
2021-11-08 8-K 8-K 2.02,9.01 0000950170-21-003301 001-37635 211386500 34 406462 1 1
2021-10-18 8-K 8-K 1.01,8.01,9.01 0000950170-21-002143 001-37635 211327310 34 273847 1 1
2021-09-16 8-K 8-K 8.01,9.01 0001193125-21-274638 001-37635 211256949 34 177502 1 1
2021-09-14 8-K 8-K 8.01,9.01 0001193125-21-272174 001-37635 211251215 34 171487 1 1
2021-08-23 8-K 8-K 8.01,9.01 0001564590-21-045336 001-37635 211195352 34 269771 1 1
2021-08-09 10-Q AXSM-10Q-06302021 0001564590-21-042710 001-37635 211157163 34 6495471 1 1
2021-08-09 8-K 8-K 2.02,8.01,9.01 0001564590-21-042348 001-37635 211154641 34 514759 1 1
2021-07-13 8-K 8-K 8.01 0001564590-21-036470 001-37635 211088382 34 164535 1 1
2021-06-15 8-K 8-K 8.01,9.01 0001564590-21-032864 001-37635 211016873 34 270458 1 1
2021-06-08 4 FORM 4 SUBMISSION 0001209191-21-038955 5344
2021-06-08 4 FORM 4 SUBMISSION 0001209191-21-038954 5152
2021-06-08 4 FORM 4 SUBMISSION 0001209191-21-038952 5267
2021-06-08 8-K 8-K 5.07,9.01 0001564590-21-031994 001-37635 211000698 34 214093 1 1
2021-05-13 4 FORM 4 SUBMISSION 0001209191-21-032250 5569
2021-05-11 S-8 S-8 0001564590-21-026618 333-256019 21912584 33 99392
2021-05-10 10-Q 10-Q 0001564590-21-026119 001-37635 21908197 34 5900684 1 1
2021-05-10 8-K AXSM-8K_1Q2021 2.02,9.01 0001564590-21-026107 001-37635 21908073 34 317913 1 1
2021-04-26 8-K 8-K 8.01,9.01 0001564590-21-020419 001-37635 21851530 34 204315 1 1
2021-04-23 DEF 14A DEF 14A 0001564590-21-020383 001-37635 21850632 34 3832067
2021-04-19 SEC STAFF LETTER filename1.pdf 9999999997-21-001367 274627
2021-03-22 SEC STAFF LETTER filename1.pdf 9999999997-21-000968 276927
2021-03-09 4 FORM 4 SUBMISSION 0000899243-21-010811 8356
2021-03-09 4 FORM 4 SUBMISSION 0000899243-21-010809 5399
2021-03-09 4 FORM 4 SUBMISSION 0000899243-21-010807 8381
2021-03-09 4 FORM 4 SUBMISSION 0000899243-21-010806 8274
2021-03-09 4 FORM 4 SUBMISSION 0000899243-21-010805 5323
2021-03-09 4 FORM 4 SUBMISSION 0000899243-21-010804 5207
2021-03-01 10-K 10-K 0001564590-21-009924 001-37635 21698997 34 10490296 1 1
2021-03-01 8-K 8-K 2.02,9.01 0001564590-21-009639 001-37635 21693778 34 358001 1 1
2021-02-24 8-K 8-K LEERINK PRESENTATION 8.01,9.01 0001564590-21-008173 001-37635 21674840 34 1832144 1 1
2021-02-10 SC 13G SCHEDULE 13G 0001104659-21-017538 005-89198 21610174 34 13790
2021-02-04 SC 13G axsome13g12312020.htm 0001033427-21-000006 005-89198 21588957 34 59093
2021-01-29 SC 13G/A us05464t1043_012821.txt 0000834237-21-002806 005-89198 21566801 34 13399
2021-01-28 8-K 8-K 7.01 0001558370-21-000473 001-37635 21562063 34 158886 1 1
2020-12-31 8-K 8-K 8.01,9.01 0001558370-20-014582 001-37635 201427482 34 254363 1 1
2020-12-23 4/A OWNERSHIP DOCUMENT 0001104659-20-139275 8769
2020-12-23 4/A OWNERSHIP DOCUMENT 0001104659-20-139274 8744
2020-12-08 8-K 8-K 8.01,9.01 0001558370-20-014236 001-37635 201374393 34 225272 1 1
2020-12-02 8-K 8-K 8.01,9.01 0001558370-20-014137 001-37635 201362392 34 222539 1 1
2020-12-01 8-K 8-K 8.01,9.01 0001558370-20-014109 001-37635 201359765 34 244123 1 1
2020-11-06 10-Q/A 10-Q/A 0001558370-20-013181 001-37635 201295083 34 352955 1 1
2020-11-05 10-Q 10-Q 0001558370-20-012949 001-37635 201291601 34 6921468 1 1
2020-11-05 8-K 8-K 2.02,8.01,9.01 0001558370-20-012942 001-37635 201291523 34 6623459 1 1
2020-09-29 8-K 8-K 1.01,1.02,2.03,3.02,8.01,9.01 0001558370-20-011292 001-37635 201206000 34 219477 1 1
2020-09-24 8-K 8-K 8.01,9.01 0001558370-20-011257 001-37635 201193501 34 205973 1 1
2020-09-22 8-K/A FORM 8-K/A 8.01,9.01 0001104659-20-107108 001-37635 201187564 34 247395 1 1
2020-09-21 8-K FORM 8-K 8.01,9.01 0001104659-20-106744 001-37635 201185175 34 242452 1 1
2020-09-16 8-K 8-K 8.01,9.01 0001558370-20-011179 001-37635 201177397 34 7209319 1 1
2020-09-14 8-K FORM 8-K 8.01,9.01 0001104659-20-104587 001-37635 201172260 34 242254 1 1
2020-09-08 8-K FORM 8-K 5.02 0001104659-20-103082 001-37635 201164552 34 200245 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (304 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 52.60M 2026-10-26 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
dei EntityPublicFloat Entity Public Float USD 4.40B 2025-06-30 2025 FY 10-K 2026-02-23 0001193125-26-064267
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 0 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177610
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 11.04M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177610
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.59M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177610
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177610
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 33.80M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177610
ecd PeoTotalCompAmt PeoTotalCompAmt USD 10.28M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177610
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 224.18 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177610
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 331.76M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 96.08M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 343.11M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 3.39M 2018-09-30 2018 Q3 10-Q 2018-11-09 0001558370-18-009181
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 15.59M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap AccruedSalesCommissionCurrent Accrued Sales Commission, Current USD 228.64M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 384.89M 2020-09-30 2020 Q3 10-Q 2020-11-05 0001558370-20-012949
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.54B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 26.79M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 1.64M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap AdvertisingExpense Advertising Expense USD 170.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 76.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 491,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 4.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 7.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap Assets Assets USD 826.77M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap AssetsCurrent Assets, Current USD 724.64M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -211,571 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-18 0000950170-25-022457
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 74,065 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-18 0000950170-25-022457
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 11.22M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 63.61M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap Cash Cash USD 86.47M 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002568
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 313.86M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -13.67M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001558370-18-006756
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 313.86M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -9.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 313.90M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 74.75 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 28,424 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 52.58M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 52.58M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap CommonStockValue Common Stock, Value, Issued USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 0 2017-12-31 2017 FY 10-K 2018-03-07 0001558370-18-001639
us-gaap CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization USD 46.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap CostOfRevenue Cost of Revenue USD 5.20M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-004728
us-gaap CostsAndExpenses Costs and Expenses USD 793.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 15.30M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-07 0001558370-18-001639
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 120.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap DebtInstrumentUnamortizedDiscountCurrent Debt Instrument, Unamortized Discount, Current USD 64,375 2019-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009924
us-gaap DebtInstrumentUnamortizedDiscountNoncurrent Debt Instrument, Unamortized Discount, Noncurrent USD 1.93M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 264,395 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-07 0001558370-17-001426
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 7.10M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 5.35M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 323.25M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 34,000 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 121.36M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 14.06M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 38.77M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 4,000 2024-12-31 2024 FY 10-K 2025-02-18 0000950170-25-022457
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 65,000 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 24.72M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 35.68M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 8.68M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 316.11M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs USD 121,875 2019-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009924
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 6.74M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 19,985 2016-12-31 2018 FY 10-K 2019-03-15 0001558370-19-002068
us-gaap Depreciation Depreciation USD 387,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.48 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.03 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-02 0000950170-22-006901
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.48 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.002 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.098 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.063 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent pure -0.011 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.109 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0.005 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.021 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.028 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.011 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet Embedded Derivative, Gain (Loss) on Embedded Derivative, Net USD 274,800 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-07 0001558370-18-001639
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 41.87M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 1.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 54.20M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -2.79M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009924
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.73 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-07 0001558370-18-001639
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.018 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-07 0001558370-18-001639
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD -2.79M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-15 0001558370-19-002068
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 2.15M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-15 0001558370-19-002068
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-14 0001558370-16-010043
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD -9.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 74.83M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 790,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 14.74M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 5.55M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 9.19M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 16.60M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 6.27M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 1,000 2024-12-31 2024 FY 10-K 2025-02-18 0000950170-25-022457
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 223,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 3.01M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 5.31M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.79M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 1.86M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 3.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 14.80M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 3.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.093 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 0 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009924
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 28.05M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 8.63M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 6.38M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 1.61M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 6.38M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 6.38M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 6.38M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 6.39M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 63.80M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 35.75M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 64.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap Goodwill Goodwill USD 12.04M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 11.90M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-004728
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0000950170-23-059470
us-gaap GoodwillPeriodIncreaseDecrease Goodwill, Period Increase (Decrease) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -128.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD -180,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 216,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD -180,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 17.94M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -38.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount USD 2.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -364,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD -19.96M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -79,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD -498,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 3.81M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap IncomeTaxReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount USD 589,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 30.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 118.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 708,237 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001558370-18-009181
us-gaap IncreaseDecreaseInIncomeTaxes Increase (Decrease) in Income Taxes USD 2.58M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-09 0000950170-23-018976
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 13.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -2.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 95.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 184,554 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0000950170-22-016143
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 35.75M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap InterestExpense Interest Expense USD -9.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap InterestExpenseDebtExcludingAmortization Interest Expense, Debt, Excluding Amortization USD 8.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap InterestIncomeOperating Interest Income, Operating USD 5.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 9.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap InterestPayableCurrent Interest Payable, Current USD 45,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 21.69M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap InventoryGross Inventory, Gross USD 13.99M 2022-09-30 2022 Q3 10-Q 2022-11-07 0000950170-22-022710
us-gaap InventoryNet Inventory, Net USD 42.58M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 10.18M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 11.40M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 0 2023-09-30 2023 Q3 10-Q 2023-11-06 0000950170-23-059470
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 19.66M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap InventoryWriteDown Inventory Write-down USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap InvestmentIncomeNet Investment Income, Net USD -4.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 264,365 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-07 0001558370-18-001639
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 870,275 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009924
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 25.81M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 1.28M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 4.79M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 5.03M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 5.03M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 11.28M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 4.81M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.39M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 4.40M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap Liabilities Liabilities USD 721.34M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 826.77M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap LiabilitiesCurrent Liabilities, Current USD 509.72M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 350.00M 2023-01-09 2025 Q1 10-Q 2025-05-05 0000950170-25-063634
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 70.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 120.00M 2025-09-30 2025 Q3 10-Q 2025-11-03 0001193125-25-262664
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 2.67M 2019-12-31 2019 FY 10-K 2020-03-12 0001558370-20-002573
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 120.00M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 120.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 15.20M 2022-09-30 2022 Q3 10-Q 2022-11-07 0000950170-22-022710
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 12.19M 2021-09-30 2021 Q3 10-Q 2021-11-08 0000950170-21-003466
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 2.67M 2020-06-30 2020 Q2 10-Q 2020-08-10 0001558370-20-010231
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 118.07M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 54.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -768,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -63.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -128.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap NumberOfReportingUnits Number of Reporting Units ReportingUnits 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap OperatingExpenses Operating Expenses USD 38.29M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-02 0000950170-22-006901
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -124.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap OperatingLeaseCost Operating Lease, Cost USD 3.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 2.20M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-23 0000950170-24-019118
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 21.41M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 663,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 20.75M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 18.28M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 314,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-09 0000950170-23-018976
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.12 2024-12-31 2024 FY 10-K 2025-02-18 0000950170-25-022457
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 577.90M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.03M 2020-09-30 2020 Q3 10-Q 2020-11-05 0001558370-20-012949
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 507,464 2022-06-30 2022 Q2 10-Q 2022-08-09 0000950170-22-016143
us-gaap OtherInventoryNoncurrent Other Inventory, Noncurrent USD 30.83M 2026-03-31 2026 Q1 10-Q 2026-05-04 0001193125-26-204274
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 20.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 309,340 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002568
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 3.64M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap PaymentsOfLoanCosts Payments of Loan Costs USD 42,620 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-07 0001558370-17-001426
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 297,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 13.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 53.00M 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-18 0000950170-25-022457
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 768,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 25.08M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 7.38M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-07 0001558370-18-001639
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 45.55M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-07 0001558370-18-001639
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 19.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 50.00M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002568
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 5,100 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-07 0001558370-17-001426
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 1.01M 2023-01-01 2023-03-31 2023 Q2 10-Q 2023-08-07 0000950170-23-039178
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 210.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD -1.67M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001558370-18-006756
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 17.04M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-05 0000950170-25-063634
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 249,836 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002568
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -128.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 943,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 210.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 41,469 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-07 0001558370-18-001639
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 149.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.43B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 669.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap Revenues Revenues USD 31.30M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-07 0000950170-23-039178
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 12.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 23.87M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD 4.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 477.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 596.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 76.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.91 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001558370-20-002573
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.87 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-12 0001558370-20-002573
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 2.72M 2016-09-30 2016 Q3 10-Q 2016-11-14 0001558370-16-010043
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 13.20M 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-004728
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 4.72M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 47.09 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 3,130 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-09 0001558370-19-004564
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 302,564 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0000950170-23-059470
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 390,395 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 89.06 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 6,169 2024-03-31 2024 Q1 10-Q 2024-05-06 0000950170-24-053697
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 732,273 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 5.61M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 53.75 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 647,627 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 732,273 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 5.61M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 53.75 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 42.08 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 54.76 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-004728
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 52.17 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0000950170-23-059470
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 125.2 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap SharePrice Share Price USD/shares 5.325 2017-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002568
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 39,000 2019-04-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001558370-19-007735
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 105.43M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 7.345 2015-10-30 2017 FY 10-K 2018-03-07 0001558370-18-001639
us-gaap StockIssued1 Stock Issued USD 8.00M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001558370-20-012949
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 2.37M 2015-11-01 2015-11-30 2016 Q3 10-Q 2016-11-14 0001558370-16-010043
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1.78M 2017-12-01 2017-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002568
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 1.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 264,395 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-15 0001558370-19-002068
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 59.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 5,100 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-07 0001558370-17-001426
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 9.50M 2017-12-01 2017-12-31 2021 FY 10-K 2022-03-01 0000950170-22-002568
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 9.98M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate Tax Cuts and Jobs Act, Measurement Period Adjustment, Increase (Decrease) in Effective Tax Rate pure -25.4 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-12 0001558370-20-002573
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 101,000 2025-12-31 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 3.27M 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 3.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 34.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001193125-26-064267
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 0 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009924
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 51.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 38.32M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-02 0000950170-22-006901
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 51.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443752

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →